Friday, October 3, 2008

Type 1 (reversal) reaction

Leprosy Mailing List, September 15th, 2008

Ref.: Type 1 (reversal) reaction
From: van Brakel W., Amsterdam, Netherlands


Dear Dr. Ranawaka,

I refer to you paper dated LML Aug. 25th, 2008. Yes, recurrent type 1 reaction (T1R) is well-known in lepromatous leprosy. This is then assumed to be the 'sub-polar' type, but I wouldn't claim I could tell the difference between polar and sub-polar, nor is it relevant to treatment. T1R in multibacillary (MB) leprosy should be treated with a longer course of steroids; 6 months is recommended (see e.g. Becx-Bleumink & Berhe, Int Lep J, 1992 and Rao et al, Leprosy Rev 2006). Recurrence during and just after tapering of steroids is often seen and was also documented in our recent INFIR Cohort Study in India, though we have not published specifically on recurrent reaction yet.

With friendly greetings,

Wim

Wim H. van Brakel
KIT Leprosy Unit
Wibautstraat 137
J1097DN Amsterdam
Netherlands
+3120 6939297
w.v.brakelatkit.nl
www.kit.nl

Request about: "Leprosy, society and stigma: an anthropological study in an urban setting”

Leprosy Mailing List, September 15th, 2008

Ref.: Request about: "Leprosy, society and stigma: an anthropological study in an urban setting”.
From: Sukhbir Singh, Chandigarh, Panjab, India


Respected Sir ,
I am a research scholar in the Department of Anthropology, Panjab University, Chandigarh. I am doing my research work on the topic "Leprosy, society and stigma: an anthropological study in an urban setting”.
Sir I need some favour from you. Sir I need a “model” to study the stigma of leprosy patients (e.g. a theoretical framework or any scale to measure stigma). If you have information about relevant material or references please let me know so that I can use in my research work. They will be correctly acknowledged in the thesis.

Thanking you.
Yours sincerely,

Sukhbir SinghResearch ScholarDepartment of AnthropologyPanjab UniversityChandigarh
India
Postal address:-# B-729, Rathpur Colony, Pinjore,District- Panchkula,Haryana- 134102

Management of type 1 (reversal) reaction

Leprosy Mailing List, September 15th, 2008

Ref.: Management of type 1 (reversal) reaction
From: Periche Fernandez J., Santo Domingo, Dominican Republic


Dear Salvatore,
This is about the request of information about treatment of type 1 (reversal) reaction from Dr Ranawaka R., from Anuradhapura, Sri Lanka dated Mon, August 25, 2008.

Dr Ranawaka reported a 60 year old woman with lepromatous leprosy (LL) and presenting with type 1 reaction. She was treated with oral prednisolone for 3 months. At the tapering off of prednisolone she developed recurrence of type 1 reaction twice. Dr Ranawaka’s questions are:-

Question 1.
”Is type 1 reaction described in lepromatous leprosy?”
No! type one reactions are seen in borderline (BT, BB, BL) cases, if the reaction is really type 1 then the patient is not LL, but she probably is a BL case. This means a borderline case but close to the LL side on the leprosy spectrum. Alternatively the patient may have sub polar lepromatous leprosy (LLs). On the other hand it might be that the patient is having a type 2 reaction! A carefully look at biopsy taken form the lesions and a new bacteriology, both compared to previous biopsy and bacteriology might give the clue and tell the difference. If there are ENL like nodules this will give diagnosis of the type 2 reaction.

Question 2.
“Is there a recurrent type of type 1 (reversal) reaction?”
Yes. Both types of reactions are recurrent.

Question 3.
“Is the 3 month course of oral prednisolone the standard treatment?”
No. Some patients need longer than that.
There may also be a late reaction; that is to say a reaction after ending MDT. Biopsy and bacteriology are necessary to rule out the presence of live acid fast bacilli (these would indicate the need for prolongation of antibacterial therapy).

Regards,
Dr. Juan Periche Fernandez
Medico-DermatologoDirector Unidad de Lepra del Distrito Nacional
Coordinador Comite de etica interno (Internal review board)
Instituto Dermatologico y Cirugia de PielDr Huberto Bogaert Diaz (IDCP-Dr.HBD)
office (809) 684-3257 ext 234
Fax (809) 681-7687
Apartado postal 1090Corazones Unidos
Dermatologia y Cosmiatria(809) 683-6185mobile (809)815-1060
e mail: jpericheathvtudr.org
Santo Domingo DN, Rep Dominicana

Friday, September 12, 2008

Leprosy Mailing List, September 11th, 2008

Ref.: Leprosy in children and INFOLEP
From: v Brakel W., Amsterdam, The Netherlands

Dear Salvatore,

I refer to Dr Sunil Deepak LML message dated Sept. 5th 2008. I have already written a specific suggestion to Sunil, but would like to remind LML readers that such requests for articles, etc. can also be addressed to the now joint ILEP/NLR resource centre INFOLEP. Requests should be addressed to:
infolep@leprastichting.nl.
More information about INFOLEP and its resources can be found on the new ILEP website: www.ilep.org.uk.

With best wishes,

Wim van Brakel

KIT Leprosy Unit
w.v.brakelatkit.nl

Leprosy in children

Leprosy Mailing List, September 11th, 2008

Ref.: Leprosy in children
From: Faria Rodrigues C. A., Passos, MG, Brazil

Dear Salvatore,
I think many of us around the world like Dr Sunil Deepak (LML Sep. 5th, 2008) have the same problem with “leprosy in children” and those monographs and articles he asked for, on this theme will be useful to all of us.
Thanks.
With best wishes,
Dr Carlos Alberto Faria Rodrigues
Av. Arouca 660 Sala 1014 – Passos – Minas Gerais – BrazilTel: +55 (35) 3521-7811Email dermorlatpassosnet.com.br Webpage: www.hanseniase2.passosuemg.br

Leprosy in children

Leprosy Mailing List, September 11th, 2008

Ref.: Leprosy in children
From: Ryan T., Oxford, UK


Dear Salvatore,
I refer to Dr Deepak’s LML message dated Sept. 5th, 2008. Very important to emphasise that anything that switches on repair of the epidermis accelerates its cell turnover and melanisation may not be able to keep up. Mild dermatitis is very common due a range of climate effects, infections and irritants. It results in hypopigmentation, so white patches in children are common (Pityriasis alba) and respond to emollients. Sweating is not pronounced in children and therefore its absence un helpful. The memory of leprosy has to be sown in every medical student and of course the basic skill of sensory testing.

In Children, facial pityriasis alba cannot so easily be distinguished since the facial innervation defects in leprosy white patches in children are difficult to define. One hesitates to biopsy a child's face but persistent white patches else where on the body, not responding to emollients or antifungals should be biopsied. As has been pointed out by Margaret Lockwood in the UK the memory of leprosy is often triggered by the Dermatologists habit of taking a biopsy.

This is a preface to ask you not to focus on this rare disease out of context of the many other causes of skin disease but to emphasise the importance of the skin, its barrier function, communication role, themoregulation, and sensory function and encourage them to avoid the ignorance that prevails world wide on how to manage it.

Most of dermatology's textbooks and Internet are well equipped to answer questions on the diagnosis of skin lesions in Children. Think of leprosy should be the main teaching point.

Terence Ryan

11th congress of the Brazilian Society of Leprology. Porto Alegre, Brazil, 24-26 November 2008

Leprosy Mailing List, September 11th, 2008

Ref.: 11th congress of the Brazilian Society of Leprology. Porto Alegre, Brazil, 24-26 November 2008
From: Theuvenet W., Apeldoorn, The Netherlands


Dear Salvatore,

Warm regards from the Netherlands!

To visit the 11th congress of the Brazilian Leprology Society (Porto Alegre, Brazil, 24-26 November 2008) sounds like a real learning experience be it that the announcement comes in a bit late for some agendas. Are dates for the 12th congress already set?

Warm regards,

Wim